Cengild Medical Berhad (0243) — Cash Flow Reinvestment Rate
Cengild Medical Berhad (0243) has a Cash Flow Reinvestment Rate of 78.92x as of December 2025, reinvesting RM74.73 Million (capex RM36.98 Million plus investments RM37.75 Million) from operating cash flow of RM947.00K. Explore 0243 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cengild Medical Berhad Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Cengild Medical Berhad across 6 annual periods. Also explore Cengild Medical Berhad total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Cengild Medical Berhad (2020–2025)
Year-by-year capital reinvestment analysis for Cengild Medical Berhad. For live market cap and broader valuation context, see 0243 company net worth.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.28x | RM52.68 Million | RM16.08 Million | RM37.26 Million | ▼ -48.3% |
| 2024 | 6.33x | RM81.91 Million | RM12.94 Million | RM15.73 Million | ▲ +65.1% |
| 2023 | 3.84x | RM52.78 Million | RM13.76 Million | RM2.13 Million | ▲ +11.3% |
| 2022 | 3.45x | RM48.43 Million | RM14.05 Million | RM427.67K | ▲ +1231.9% |
| 2021 | 0.26x | RM3.70 Million | RM14.30 Million | RM1.70 Million | ▲ +11.4% |
| 2020 | 0.23x | RM2.61 Million | RM11.24 Million | RM610.08K | — |